(19)
(11) EP 1 089 979 A1

(12)

(43) Date of publication:
11.04.2001 Bulletin 2001/15

(21) Application number: 99930715.0

(22) Date of filing: 25.06.1999
(51) International Patent Classification (IPC)7C07D 241/44, C07D 401/06, C07D 405/06, A61K 31/495
(86) International application number:
PCT/US9914/395
(87) International publication number:
WO 0000/478 (06.01.2000 Gazette 2000/01)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
LT LV RO SI

(30) Priority: 26.06.1998 US 90893 P

(71) Applicant: Du Pont Pharmaceuticals Company
Wilmington, DE 19807 (US)

(72) Inventors:
  • PATEL, Mona
    Wilmington, DE 19810 (US)
  • MCHUGH, Robert, Joseph
    Newark, DE 19702 (US)

(74) Representative: Beacham, Annabel Rose et al
Frank B. Dehn & Co.,European Patent Attorneys,179 Queen Victoria Street
London EC4V 4EL
London EC4V 4EL (GB)

   


(54) SUBSTITUTED QUINOXALIN-2(1H)-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS